ADMA Biologics comprises 3.2% of Palisades Investment Partners LLC’s portfolio, making the stock its 10th biggest holding. Palisades Investment Partners LLC’s holdings in ADMA Biologics were worth $7,259,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Get ADMA Biologics alerts:ADMA Biologics Stock PerformanceADMA Biologics stock opened at $15.61 on Friday. ADMA Biologics ProfileADMA Biologics ( NASDAQ:ADMA Get Free Report ) last issued its quarterly earnings results on Wednesday, August 6th. Receive News & Ratings for ADMA Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ADMA Biologics and related companies with MarketBeat.com's FREE daily email newsletter.